Rising Penetration Of Deep Brain Stimulation Devices For The Treatment Of Neurological Diseases Will Boost Product Demand In The Forecast Period

The deep brain stimulation devices market is anticipated to witness a CAGR of 12.34% in the forecast period. Deep brain stimulation (DBS) is an operation carried out to insert a device that sends electrical signals to brain areas responsible for body movement. Comparable to heart stimulators, the neurostimulator uses electrical pulses to regulate brain activity. Thus, it can reduce symptoms of neurological diseases like essential tremor, Parkinson’s disease, or dystonia and lower medication doses to improve quality of life. This, in turn, will escalate product demand in the forecast period. For instance, Medtronic DBS, Abbott St. Jude Medical Infinity DBS, and Boston Scientific Vercise DBS devices gained FDA approval for Parkinson’s disease.

Drivers and Restraints

Enhancement in DBS devices will propel product demand in the forecast period. These enhancements includes use of innovative technology like multi-target stimulation, microelectrode design, and individualized directed programming. Factors such as lack of awareness among consumers regarding the benefits of DBS and high cost of product will restrain overall industry growth. Also, the high cost of brain surgery and lack of developed healthcare infrastructure in emerging economies like India will show a negative impact on overall business growth in the forecast period.

Deep brain stimulation devices industry is categorized based on product type, applications, and region. Based on product type, the industry is categorized into dual-channel DBS and single-channel DBS. Based on applications, the industry is categorized into Dystonia, Parkinson’s disease, essential tremor, and others. Geographically, the industry is categorized into Middle East and Africa, Asia Pacific, South America, North America, and Europe.

Access "100" page research report with TOC on "Deep Brain Stimulation Devices Market" available with Radiant Insights, Inc.@ https://www.radiantinsights.com/research/global-deep-brain-stimulation-devices-market-insights-and-forecast-to-2026-by-top-companies

Rising occurrence of Parkinson’s disease will stimulate DBS device demand in the forecast period.

Parkinson’s disease segment is anticipated to remain dominant in terms of volume and revenue over the forecast period. High medication costs and fewer treatment alternatives will lead to use of DBS devices for treating Parkinson’s disorder. This, in turn, will propel product demand in the forecast period. As per the Parkinson Foundation, about 10 million people suffering from Parkinson’s disease across the globe. Thus, DBS devices play an important role in reducing this number and will boost industry growth.

Asia Pacific is anticipated to boost the rate of DBS adoption owing to rising incidence of psychiatric and neurodegenerative disorders in the region.

Rising investment by major players owing to the obtainability of low cost labor in the region will boost adoption of DBS. The economies like India and China are major consumers in this region owing to rising expenditure and awareness regarding enhanced healthcare technology. India is anticipated to witness the fastest growth rate in the projected period. As per the report published by World Health Organization (WHO) states that over 7.5% population suffers from brain diseases, which in turn leads to high demand for diagnosis and surgical treatments. Thus, rising rate of brain diseases in India will thrust business outlook in the near future.

Prominent players of the deep brain stimulation devices market include SceneRay, Medtronic, Beijing Pins, Boston Scientific, and St Jude Medical. These players are concentrating on the expansion of business by integrating novel technology to develop an enhanced product portfolio in the forecast period. This, in turn, will increase overall industry revenue share in the coming years. For instance, Medtronic launched its DBS Clinician Programmer to expand its business across the globe.